Efficacy of Vaccination with the DIVENCE® Vaccine Against Bovine Viral Diarrhea Virus Types 1 and 2 in Terms of Fetal Protection
DIVENCE<sup>®</sup> administered prior to breeding protected 94% of the fetuses against BVDV transplacental infection overall across both challenge trials (BVDV-1 and BVDV-2). A reduction in the hyperthermia, leukopenia, viral shedding, and viremia in vaccinated animals post-challenge with BVDV-1 and BVDV-2 was achieved. The efficacy of DIVENCE<sup>®</sup> against BVDV-1 and BVDV-2 transplacental infection has been demonstrated in this study.
Authors
- E. Taberner (ORCID: https://orcid.org/0000-0003-2655-6261)
- Isaac Ruiz (ORCID: https://orcid.org/0000-0002-3711-1287)
- Joaquim Mallorquí
- Carlos Montbrau (ORCID: https://orcid.org/0000-0003-0563-6414)
- Ricard March (ORCID: https://orcid.org/0000-0003-2396-4163)
- Héctor Santo Tomás
- Marta Gibert
- Antoni Prenafeta
Publication Details
- Journal
- Veterinary Medicine Research and Reports
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/vmrr.s474655
- Citations
- 1
- Primary Topic
- Animal Disease Management and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.57